EFPIA Newsletter 23 February 2023

Innovation is delivering therapies for people with rare diseases – but R&D needs support       Nathalie Moll discusses the importance of investment in R&D in Europe to tackle unmet medical needs. Read more →

News     17 February 2023 EFPIA rejoinder Lancet article Read more →         09 February 2023 Industry Statement on the earthquakes in Turkey and Syria Industry will continue to work with partners and authorities across Europe to provide further support where possible.... Read more →

Blogs     23 February 2023 How regulation can boost the EU innovation? Technology moves fast. An agile and streamlined innovation ecosystem would make Europe more competitive and bring breakthroughs... Read more →

Events     28 FEB 2023   Let’s make a joint health check for CVD and diabetes happen European Parliament Join us in the European Parliament from 28 February - 2 March for a week of insights, events and perspectives from people... Learn more →       28 FEB 2023   3rd International conference on Rare Diseases: Greek chapter Technopolis City of Athens Under the theme “Leveraging the momentum for a comprehensive rare disease strategy”, the 3rd International Conference... Learn more →

	13 MAR 2023			Women’s Brain Project special webinar Online Sex, gender and the brain: Towards an inclusive research agenda Learn more →

	16 MAR 2023			GetReal Institute Annual Conference 2023 Utrecht, Netherlands A European Outlook on Real World Evidence in a Global Context Learn more →

What we are reading Joint response to Call for Evidence on a Comprehensive Approach to Mental Health 14 February 2023  (European Association of Urology) Read more → IFPMA Ethoscope 17 February 2023  (IFPMA) Read more → Vaccination drive: buses roll into Ukraine to boost vaccination 21 February 2023  (Vaccines Today) Read more → EU Health Summit 2023 Event Report 23 February 2023  (EU Health Coalition) Read more →

About the EFPIA newsletter The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55 Communications@efpia.eu ▶ in

EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe